ConductScience.org, home

Paper36096045

Comparison of narrow band and fluorescence molecular imaging to improve intraoperative tumour margin assessment in oral cancer surgery.

de Wit JG and 10 others. Oral Oncol, 2022. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Comparison of narrow band and fluorescence molecular imaging to improve intraoperative tumour margin assessment in oral cancer surgery. Papers, record 36096045. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36096045

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of narrow band and fluorescence molecular imaging to improve intraoperative tumour margin assessment in oral cancer surgery.
PubMed
Journal
Oral Oncol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
2.39
iCite
Revised in PubMed
2022-11-17
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1de Wit JGJaron G
2van Schaik JEJeroen E
3Voskuil FJFloris J
4Vonk JJasper
5de Visscher SAHJSebastiaan A H J
6Schepman KPKees-Pieter
7van der Laan BFAMBernard F A M
8Doff JJJan J
9van der Vegt BBert
10Plaat BECBoudewijn E C
11Witjes MJHMax J H

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
Head and Neck NeoplasmsMajor topic
Mouth NeoplasmsMajor topic
Cetuximab
Humans
Margins of Excision
Molecular Imaging
Narrow Band Imaging
Prospective Studies

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
41327772A Panoramic View of Narrow Band Imaging in the Treatment of Head and Neck CancerCurr Med Imaging2026https://conductscience.org/library/papers/41327772PubMed
41199842Current and future burden trends of lip and oral cavity cancer based on estimated annual percentage change and the Bayesian age-period-cohort model: a study based on the global burden of disease 2021.Front Oncol2025https://conductscience.org/library/papers/41199842PubMed
41139331The Use of Narrow-Band Imaging to Improve Pathological Margin in Oral Squamous Cell Carcinoma: A Prospective Randomized Controlled Trial.J Otolaryngol Head Neck Surg2025https://conductscience.org/library/papers/41139331PubMed
40699851Early Molecular Diagnosis and Comprehensive Treatment of Oral Cancer.Curr Issues Mol Biol2025https://conductscience.org/library/papers/40699851PubMed
40400383The impact of histology and molecular biology in refining the prognostic value of surgical margins in head and neck oncology - A narrative review.Acta Otorhinolaryngol Ital2025https://conductscience.org/library/papers/40400383PubMed
40380992Intraoperative fluorescence in solid head and neck cancer: A scoping review.Eur Arch Otorhinolaryngol2025https://conductscience.org/library/papers/40380992PubMed
39698655Cutting-edge insights: near-infrared imaging for surgical margin assessment in head and neck tumor resection: a systematic review and meta-analysis.Quant Imaging Med Surg2024https://conductscience.org/library/papers/39698655PubMed
39594729Oral Mucosa Capillaroscopy: A Narrative Review.Cancers (Basel)2024https://conductscience.org/library/papers/39594729PubMed
39335128Epidemiology, Diagnostics, and Therapy of Oral Cancer-Update Review.Cancers (Basel)2024https://conductscience.org/library/papers/39335128PubMed
39251820Illuminating the future of precision cancer surgery with fluorescence imaging and artificial intelligence convergence.NPJ Precis Oncol2024https://conductscience.org/library/papers/39251820PubMed
37763165Personalized Medicine in Oral Oncology: Imaging Methods and Biological Markers to Support Diagnosis of Oral Squamous Cell Carcinoma (OSCC): A Narrative Literature Review.J Pers Med2023https://conductscience.org/library/papers/37763165PubMed
36929425BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway.Int J Oncol2023https://conductscience.org/library/papers/36929425PubMed
36765858Intraoperative Imaging Techniques to Improve Surgical Resection Margins of Oropharyngeal Squamous Cell Cancer: A Comprehensive Review of Current Literature.Cancers (Basel)2023https://conductscience.org/library/papers/36765858PubMed
36362753Stomatognathic Diseases: State of the Art and Future Perspectives.J Clin Med2022https://conductscience.org/library/papers/36362753PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36096045

GET https://conductscience.org/api/papers/v1/36096045/authors